BABU VADLAMUDI: Open Payments
NPI 1740227735 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 42 payments from 8 companies in 2025. Trend: 2023 $919 · 2024 $1,394 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $505 |
| E.R. Squibb & Sons, L.L.C. | 9 | $252 |
| Lundbeck LLC | 7 | $141 |
| Alkermes, Inc. | 5 | $126 |
| Vanda Pharmaceuticals Inc. | 5 | $103 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
Products named: REXULTI, COBENFY, ABILIFY MAINTENA, ARISTADA, HETLIOZ, INVEGA SUSTENNA, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across MI — which companies pay providers there.
